The income reported is for Zenivol in Aus only, and this is a slow process of building patients.
Sales began last quarter in Louisiana for HOPE, but this is via a third party, and we will not recognise revenues from them on a quarterly basis (they have their own U.S. reporting schedule.)
Contact the company for further info on all this.
Buying opportunity in this big 'ol retail sell off. I'll check back in 12 months. x
